XML 17 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 54,780 $ 57,445
Marketable securities (Notes 3 and 13) 140,796 133,044
Trade and other receivables, net of allowance for credit losses of $223 and $223, as of March 31, 2024 and December 31, 2023, respectively 854 816
Inventories (Note 4) 28,245 38,868
Prepaid expenses and other current assets 3,394 2,522
Total current assets 228,069 232,695
Mineral properties (Note 5) 122,406 119,581
Property, plant and equipment, net (Note 5) 29,799 26,123
Inventories (Note 4) 3,826 1,852
Operating lease right of use asset 1,174 1,219
Investments (Note 13) 1,297 1,356
Other long-term receivables 1,499 1,534
Restricted cash (Note 6) 17,717 17,579
Total assets 405,787 401,939
Current liabilities    
Accounts payable and accrued liabilities (Note 11) 5,317 10,161
Operating lease liability 209 199
Total current liabilities 5,526 10,360
Operating lease liability 1,064 1,120
Asset retirement obligations (Note 6) 11,175 10,922
Deferred revenue 332 332
Total liabilities 18,097 22,734
Equity    
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 163,651,897 and 162,659,155 as of March 31, 2024 and December 31, 2023, respectively 738,297 733,450
Accumulated deficit (352,619) (356,258)
Accumulated other comprehensive loss (1,946) (1,946)
Total shareholders' equity 383,732 375,246
Non-controlling interests 3,958 3,959
Total equity 387,690 379,205
Total liabilities and equity 405,787 401,939
Commitments and contingencies (Note 12)